Physician profile
Steven A Ohlbaum
NPI 1134118227
$1,473.59
in general payments reported to CMS, 2019-2025
9 companies · $356 in 2025
The $356 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $190 · 2021: $149 · 2022: $131 · 2023: $137 · 2024: $285 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $778.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $796.04 | 2019-2025 | Tryptyr, Precision7, Dailies Total1 |
| Coopervision INC. | $290.99 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Amgen INC. | $124.89 | 2024 | Tepezza |
| Johnson & Johnson Vision Care, INC. | $116.95 | 2019-2025 | |
| Bausch & Lomb Americas INC. | $59.33 | 2023-2025 | Infuse, Xiidra |
| Tarsus Pharmaceuticals, INC. | $25.83 | 2025 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $22.02 | 2019 | |
| Biotissue Holdings INC. | $21.06 | 2019 | |
| Kala Pharmaceuticals, INC. | $16.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Ohlbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.